GROUP ONE TRADING, L.P. - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 114082950. A total of 3 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q1 2022$21,000
-56.2%
10,200
-10.5%
0.00%–
Q4 2021$48,000
-54.3%
11,400
+0.9%
0.00%–
Q3 2021$105,000
-75.8%
11,300
-53.1%
0.00%
-100.0%
Q2 2021$434,000–24,100–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 56,800$968,0000.00%
GROUP ONE TRADING, L.P. 11,300$105,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders